We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

ZURN:SIXZurich Insurance Group Ltd Analysis

Data as of 2026-03-09 - not real-time

CHF 529.60

Latest Price

5/10Risk

Risk Level: Medium

Executive Summary

Zurich Insurance Group’s share price is trading just above a key support level while the 20‑day simple moving average sits below both the 50‑day and 200‑day averages, signaling a bearish technical backdrop. The Relative Strength Index is in the low‑30s, suggesting the stock may be oversold, yet the MACD histogram remains negative, reinforcing downside momentum. Despite a respectable 9.5% revenue growth and a return on equity above 25%, the market price is far above the discounted cash‑flow fair value estimate, indicating a material overvaluation. The company’s dividend yield exceeds 5% with a payout ratio around 72%, and cash flow generation remains solid, supporting dividend sustainability. However, the insurance sector faces medium regulatory scrutiny and the firm’s global footprint introduces moderate geographic exposure, while its low beta and rising volume point to limited price volatility.
From a fundamentals perspective, Zurich maintains a healthy balance sheet with ample cash relative to debt, strong operating margins, and a price‑to‑earnings multiple that sits below the industry average, offering a value tilt. The high dividend yield provides income appeal, but the overvalued market price and bearish technical signals temper short‑term upside expectations. Investors should weigh the income benefits against the valuation gap and sector‑specific risks when forming a position.

Market Outlook

Short Term

< 1 year
Cautious
Model confidence: 7/10

Key Factors

  • Bearish technical alignment (price below key SMAs)
  • Negative MACD and overbought valuation gap
  • High dividend yield may not offset downside risk

Medium Term

1–3 years
Neutral
Model confidence: 6/10

Key Factors

  • Solid earnings growth and cash generation
  • Sustainable dividend payout
  • Potential price stabilization near support

Long Term

> 3 years
Neutral
Model confidence: 5/10

Key Factors

  • Consistent dividend income
  • Strong balance sheet and ROE
  • Long‑term industry fundamentals despite regulatory headwinds

Key Metrics & Analysis

Financial Health

Revenue Growth9.50%
Profit Margin9.30%
P/E Ratio14.4
ROE25.22%
ROA1.72%
Debt/Equity58.82
P/B Ratio3.4
Op. Cash FlowCHF5.9B
Free Cash FlowCHF1.3B
Industry P/E17.4

Technical Analysis

TrendBearish
RSI33.9
SupportCHF 521.00
ResistanceCHF 583.60
MA 20CHF 557.80
MA 50CHF 566.60
MA 200CHF 568.72
MACDBearish
VolumeIncreasing
Fear & Greed Index75.89

Valuation

Fair ValueCHF 321.47
Target PriceCHF 567.57
Upside/Downside7.17%
GradeOvervalued
TypeValue
Dividend Yield5.66%

Risk Assessment

Beta0.38
Volatility28.26%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.